Related references
Note: Only part of the references are listed.Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Michelle Petri et al.
ARTHRITIS & RHEUMATOLOGY (2020)
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
Beuy Joob et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection
Samuel L. M. Arnold et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment
Dan M. Roden et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Initial data from the COVID-19 Global Rheumatology Alliance provider registries Reply
Milena A. Gianfrancesco
LANCET RHEUMATOLOGY (2020)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Implementation of pharmacokinetic and pharrnacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
Tove Tuntland et al.
FRONTIERS IN PHARMACOLOGY (2014)
Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies
C. R. Rayner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin
Yohichi Kumaki et al.
ANTIVIRAL RESEARCH (2011)
Share Paper
